###### Strengths and limitations of this study

-   Using ecological data to assume ambient pollutant concentrations as surrogates of individual exposure adds error.

-   In addition, pollutant concentrations were not corrected for sub-Saharan dust intrusions.

-   CIs only cover statistical uncertainty related to the risk estimates from the concentration-response functions (CRFs), currently under review by the WHO, while further uncertainty is added due to potential errors in assuming the general shape of CRFs, background pollutant levels, selection of health outcomes and structure of monitoring network.

-   In sensitivity analysis, we considered different PM~2.5~/PM~10~ ratios, background concentrations and exposure-response relationships.

-   It is difficult to generalise results to other populations as data were obtained from only one city.

Introduction {#s1}
============

Numerous epidemiological studies conducted over the past decades point to adverse health impacts from exposure to outdoor air pollution, attributing the most severe health effects to particulate matter (PM)[@R1] [@R2] and, to a lesser extent, ozone[@R3] (O~3~). New studies incorporate to the growing body of evidence,[@R4] currently under review by the WHO through projects such as REVIHAAP (Review of evidence on health aspects of air pollution) and HRAPIE (Health risks of air pollution in Europe), confirming that outdoor air pollution is an important risk factor for health.[@R7] [@R8]

According to the WHO, in the year 2012, ambient air pollution was responsible for 3.7 million deaths, representing 6.7% of the total deaths. Worldwide, ambient air pollution is estimated to cause about 16% of the lung cancer deaths, 11% of chronic obstructive pulmonary disease deaths, more than 20% of ischaemic heart disease and stroke, and about 13% of respiratory infection deaths.[@R9] Recently, the International Research Agency on Cancer (IARC) classified air pollution mixture and PM as carcinogenic to human beings (Group 1).[@R10]

It could be expected that the impact caused by a preventable risk factor would decline if the exposure to that risk factor could be reduced or removed. According to this approach, the proportional reduction in the number of health problems or deaths as a result of reducing the risk factor is known as the attributable fraction (AF).[@R11]

Estimating the environmental burden of disease associated with exposure to air pollution is critical information for policymakers who can define strategies and prioritise actions by considering the health gains that could be achieved if the exposure to the risk factor were reduced to a 'target' concentration.[@R1]

We estimated the burden of mortality from exposure to PM~10~, PM~2.5~ and O~3~ at the city of Valladolid, as a health impact assessment (HIA) under various exposure scenarios in order to provide quantitative information of the potential benefits of reducing the exposure to these pollutants.

Methods {#s2}
=======

Calculation of burden of mortality {#s2a}
----------------------------------

On the basis of the method outlined by the WHO in the Environmental Burden of Disease (EBD) series[@R1] [@R12] we followed a classical risk assessment approach: Determination of the ambient exposure of the population using data from model estimates or monitoring networks. A 'counterfactual' background or target concentration is also needed to determine the attributable disease or the potential gains of a reduction strategy.Number of people exposed to air pollutants.Baseline incidence of the adverse health outcomes associated with air pollutants (eg, the mortality rate in the population).Concentration-response functions (CRFs) that relate changes in air pollutants concentrations with changes in the incidence of adverse health effects.

Assessment of the ambient exposure of the population {#s2b}
----------------------------------------------------

About 300 000 people live in Valladolid, a Spanish city located at an altitude of 698 m in the Inner Plateau, 200 km North to Madrid. The orography of this plateau surrounded by mountains except on the border with Portugal favours winds penetrating from the Atlantic Ocean and on the contrary prevents or greatly reduces air circulation to and from the Bay of Biscay and the Southern Plateau. Notably, the Central System Range isolates Valladolid from the influence of Madrid as a great source of precursors, at least respecting direct transport at surface level. The climate is continental, with cold winters and dry summers. The pollution levels are strongly dependent on the atmospheric synoptic conditions, in this case a long and cold winter, with frequent fog events. The type of surface that surrounds the city is basically rough, bare and dry soil used primarily for agriculture. The urban aerosol corresponds to a lightly industrialised city whose contamination mostly comes from road traffic and domestic heating. Regarding economic activity, automotive sector is an important manufacturing industry. As natural sources of PM affecting occasionally the area, wildfires and wind-blown dust-like Saharan intrusions can be included. Regarding ozone, orography and solar radiation favour ozone formation and accumulation. No municipal emission source inventory has been developed yet.[@R13]

PM~10~ concentrations (annual means) were obtained from the annual reports 1999--2008 published by the Environmental Health Unit (EHU) of the city council responsible for the municipal fixed-site monitoring stations network.[@R16] O~3~ concentrations (daily maximum 8 h means) were provided on request to the EHU.The annual mean concentrations from the operating stations with a minimum data capture of 90% (operating stations with valid data according to regulatory standards)[@R17] for the 10 years of data 1999--2008 were averaged to develop the following annual average estimates for PM~10~ and O~3~: 35.41 and 141.38 μg/m^3^, respectively. As there were no direct measures of PM~2.5~, they were estimated by applying the recommended PM~2.5~/PM~10~ ratio of 0.73 for Europe.[@R1] Hence, the estimated concentration for PM~2.5~ was 25.85 μg/m^3^. [Table 1](#BMJOPEN2014005999TB1){ref-type="table"} provides a scope of our exposure data set.

###### 

PM~10~ and O~3~ concentration data set

  Pollutant   Year   Number of operating stations   Operating stations with valid data   Minimum   Maximum   Annual average   SD
  ----------- ------ ------------------------------ ------------------------------------ --------- --------- ---------------- --------
  PM~10~      1999   7                              2                                    44        47        45.5             2.121
  2000        7      7                              33                                   47        41.6      5.127            
  2001        7      4                              38                                   46        42.7      3.695            
  2002        8      4                              25                                   39        33.3      5.909            
  2003        6      6                              23                                   39        30.2      6.853            
  2004        6      4                              33                                   52        39.5      8.583            
  2005        6      6                              31                                   49        36.2      6.911            
  2006        6      5                              30                                   41        36.4      4.393            
  2007        5      5                              20                                   31        25.6      4.159            
  2008        6      4                              22                                   26        23.3      1.893            
  O~3~        1999   4                              4                                    89        134       111.5            19.638
  2000        4      4                              101                                  152       121.3     21.930           
  2001        4      2                              122                                  130       126       5.657            
  2002\*      3      1                              126                                  168.7     147.3     30.169           
  2003        4      3                              165                                  174       168.7     4.726            
  2004        3      3                              142                                  164       149.7     12.423           
  2005        3      3                              146                                  159       154.7     7.506            
  2006        3      3                              138                                  151       142.7     7.234            
  2007        3      3                              137                                  146       143       5.196            
  2008        3      3                              138                                  160       149       11               

\*In 2002 1 of 3 stations could provide valid data so it was decided to use the average of the years 2001 and 2003.

PM, particulate matter.

Population exposed and mortality data {#s2c}
-------------------------------------

Annual population figures from the municipal register and annual deaths by different causes and age groups (underlying causes of death selected according to WHO[@R1] [@R8] [@R20] and coded in accordance with the International Classification of Diseases (ICD) 10th version), extracted from the Spanish Statistical Office for 1999--2008,[@R21] were averaged and rounded off to the nearest whole number to obtain population and mortality figures for different age groups. In doing so, respiratory mortality for children \<5 years old resulted zero. Crude mortality rates (in deaths per 100 000 people) for each age group and health outcomes were calculated. [Table 2](#BMJOPEN2014005999TB2){ref-type="table"} describes population indicators and mortality rates by age group for the period of analysis.

###### 

Population data and cause-specific mortality by age group (1999--2008)

  ------------ ------------------------------- --------------------------- --------------------------
  All ages                                                                 
  Population   All-cause (natural) mortality   Respiratory mortality       Cardiovascular mortality
  319.482      2.563                           267                         872
               Mortality rate\*                                            
               802                             83                          273
  \>30 years                                                               
  Population   All-cause (natural) mortality   Cardiopulmonary mortality   Lung cancer mortality
  212.702      2.535                           729                         142
               Mortality rate\*                                            
  1.192        342                             67                          
  \<5 years                                                                
  Population   All-cause (natural) mortality   Respiratory mortality†      
  11.752       12                              0                           
               Mortality rate\*                                            
  100          2                                                           
  ------------ ------------------------------- --------------------------- --------------------------

International Classification of Diseases 10th version: all-cause (natural) mortality: all except V01-Y89; respiratory mortality: J00-J99; cardiovascular mortality: I00-I99; cardiopulmonary mortality: I00-I02; I10-I15; I20-I49; I51-I52; J00-J99; lung cancer mortality: C33-C34.

\*Mortality rate in deaths per 100 000 people.

†There were two cases of death of respiratory mortality for children \<5 years in 2003 (period 1999--2008). The annual average of respiratory mortality for 1999--2008, rounded off to the nearest whole number, resulted 0. Hence, the respiratory mortality rate per 100 000 people is 2.

Concentration-response functions {#s2d}
--------------------------------

Epidemiological studies can use regression models that generate relative risk (RR) functions with a β-coefficient that relates the per cent change in the health outcome to a unit change in air pollutant concentration, that is, an increase of the risk per 10 μg/m^3^ PM~10~. CRFs are equations derived from epidemiological studies that link the change in the number of adverse health effect incidences in a population to a change in pollutant concentration experienced by that population. Existing studies have reported either a β-coefficient or a RR. Additionally, 95% CIs are provided for the β-coefficients and RR estimates in order to obtain upper and lower bounds of the health impacts.[@R1] [@R8] [@R20]

According to the WHO and depending on data availability, we used the recommended and alternative risk functions summarised in [table 3](#BMJOPEN2014005999TB3){ref-type="table"} to calculate the RR for the following mortality outcomes associated with exposure to PM~10~, PM~2.5~ and O~3.~[@R1] [@R8] [@R20] As not all of the listed outcomes can be reliably converted into DALYs (disability-adjusted life years) estimates and owing to data availability, preference was given to mortality instead of morbidity indicators or DALYs estimates as the health effect for this assessment. Short-term estimates should not be added to long-term estimates or estimates for children, since that would involve some double counting of the mortality cases.[@R1] All-cause (natural) mortality associated with short-term exposure to PM~10~ for all ages.[@R1] These results should not be added to the other mortality estimates. DALYs cannot be determined for each of these premature deaths but can be used as an alternative to DALYs, and used as a basis for comparing short-term and long-term effects of pollutant exposure.[@R1]All-cause (natural) and respiratory mortality in infants and children \<5 years old related to short-term exposure to PM~10.~[@R1] The application of this rate to all-cause mortality could however represent an upper boundary of disease burden caused by outdoor air pollution, but may result in an overestimate when applied to certain regions.[@R1]All-cause (natural) mortality associated with long-term exposure to PM~2.5~ for \>30 years old.[@R8] The recommended risk coefficient is based on the meta-analysis of cohort studies published by Hoek *et al*[@R4] According to the HRAPIE report (2013), preference was given to use of the all-cause function instead of cause-specific indicators.[@R8]Cardiopulmonary and lung cancer mortality related to long-term exposure to PM~2.5~ for \>30 years old.[@R1] The long-term estimate should not be added to the estimate for short-term exposure, since this would double count a portion, if not all, of the short-term cases.[@R1]All-cause (natural), respiratory and cardiovascular mortality related to short-term exposure to O~3~ for all ages.[@R8] [@R20] Using two different sets of risk coefficients estimates for the same outcomes (from Anderson *et al* and the HRAPIE report, 2013) enabled the results under these assumptions to be compared. The coefficients summarised by Anderson *et al*[@R20] were revised for publication bias.

###### 

Health outcomes and risk functions used to calculate the burden of disease associated to PM~10~, PM~2.5~ and O~3~

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome and exposure metric                                                          RR function\*               β-coefficient/RR (95% CI)   Age group    ICD-10 codes
  ------------------------------------------------------------------------------------ --------------------------- --------------------------- ------------ ---------------------------------------------
  All-cause (natural) mortality and short-term exposure to PM~10~                      RR=exp \[β (X−X~o~)\]       0.0008[@R1]\                All ages     All except V01-Y89
                                                                                                                   (0.0006 to 0.0010)                       

  All-cause (natural) and respiratory mortality and short-term exposure to PM~10~†     RR=exp \[β (X−X~o~)\]       0.00 166[@R1]\              \<5 years    All except V01-Y89/J00-J99‡
                                                                                                                   (0.00 034 to 0.0030)                     

  All cause (natural) mortality and long-term exposure to PM~2.5~                      RR=exp \[β (X−X~o~)\]       1.062[@R8]\                 \>30years    All except V01-Y89
                                                                                                                   (1.040 to 1.083)                         

  Cardiopulmonary mortality and long-term exposure to PM~2.5~ (log-linear exposure)§   RR=\[(X+1)/(X~o~)+1)\]^β^   0.15 515[@R1]\              \>30 years   I00-I02 ;I10-I15 ;I20-I49 ;I51-I52 ;J00-J99
                                                                                                                   (0.0562 to 0.2541)                       

  Cardiopulmonary mortality and long-term exposure to PM~2.5~ (linear exposure)        RR=exp \[β (X−X~o~)\]       0.00 893[@R1]\              \>30 years   I00-I02 ;I10-I15 ;I20-I49 ;I51-I52 ;J00-J99
                                                                                                                   (0.00 322--0.01 464)                     

  Lung cancer and long-term exposure to PM~2.5~ (log-linear exposure)§                 RR=\[(X+1)/(X~o~)+1)\]^β^   0.23 218[@R1]\              \>30 years   C33-C34
                                                                                                                   (0.08 563 to 0.37 873)                   

  Lung cancer and long-term exposure to PM~2.5~ (linear exposure)                      RR=exp \[β (X−X~o~)\]       0.01 267[@R1]\              \>30 years   C33-C34
                                                                                                                   (0.00 432 to 0.02 102)                   

  All-cause mortality and short-term exposure to O~3~                                  RR=exp \[β (X−Xo)\]         1.002[@R20]\                All ages     All except V01-Y89
                                                                                                                   (1.0005 to 1.0035)\                      
                                                                                                                   1.0029[@R8]\                             
                                                                                                                   (1.0014 to 1.0043)                       

  Respiratory mortality and short-term exposure to O~3~                                RR=exp \[β (X−Xo)\]         0.999[@R20]\                All ages     J00-J99
                                                                                                                   (0.995 to 1.004)\                        
                                                                                                                   1.0029[@R8]\                             
                                                                                                                   (0.9989 to 1.0070)                       

  Cardiovascular mortality and short-term exposure to O~3~                             RR=exp \[β (X−Xo)\]         1\. 004[@R20]\              All ages     I00-I99
                                                                                                                   (1.003 to 1.005)\                        
                                                                                                                   1.[0049]{.ul}[@R8]\                      
                                                                                                                   (1.0013 to 1.0085)                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*X=current pollutant concentration (μg/m^3^) and X~o~=target or threshold pollutant concentration (μg/m^3^).

†All-cause mortality for upper bound where applicable.

‡Respiratory mortality.

§Recommended relationship.

ICD-10 codes, International Classification of Diseases 10th version; PM, particulate matter; RR, relative risk.

Examining the sensitivity of the results to alternative assumptions is recommended.[@R1] A sensitivity analysis was conducted using alternative values for these parameters: PM~2.5~/PM~10~ ratio: an alternative ratio of 0.65[@R1] [@R8] that results in an estimated PM~2.5~ concentration of 23.01 µg/m^3^ was examined. This ratio is considered an average for the European population by the HRAPIE report. However, in specific locations the ratio may be in the range 0.4--0.8.[@R8]Background concentrations for PM~2.5~ and O~3~[@R1] [@R3] [@R22]: 7.5 and 50 µg/m^3^, respectively.Shape of the CRF: for cardiopulmonary and lung cancer mortality associated with PM~2.5~ exposure a linear model was examined as an alternative to the recommended log-linear relationship.[@R1]

Those RR functions in [table 3](#BMJOPEN2014005999TB3){ref-type="table"} compare current measured pollutant concentrations with a counterfactual level (a hypothetical 'natural' background or a 'target' concentration). Therefore, two kinds of calculations can be made[@R1]: The total number of attributable deaths (ADs) due to current air pollution levels.The number of deaths that could be prevented if the target concentration were achieved (targeted avoidable deaths, TADs).

The only difference between the two calculations is the counterfactual level used in (1) it is the 'natural' background level (ie, the level that would exist without any man-made pollution) and (2) it is a 'target' concentration.[@R1] Different counterfactual concentrations were selected to reflect different exposure scenarios, as described following.

The counterfactual concentrations used for PM~10~ were: 10 µg/m^3^: background level scenario.[@R1]20 µg/m^3^: target value scenario from the WHO Air Quality Guidelines (AQG).[@R23]40 µg/m^3^: target value scenario from the Directive 2008/50/EC.[@R19]

Four counterfactual concentrations were used for PM~2.5~: 3 µg/m^3^: background level scenario.[@R1]10 µg/m^3^: target value scenario from the WHO AQG.[@R23]25 µg/m^3^: target value scenario from the Directive 2008/50/EC.[@R19]7.5 µg/m^3^: alternative background level for sensitivity analysis.[@R1] [@R22]

Four counterfactual concentrations were used for O~3~: 70 µg/m^3^: background level scenario from the WHO AQG.[@R23]100 µg/m^3^: target value scenario from the WHO AQG.[@R23]120 µg/m^3^: target value scenario from the Directive 2008/50/EC.[@R19]50 µg/m^3^: alternative background level for sensitivity analysis.[@R3]

Once the RRs have been computed, the AF is determined in the classic attributable risk calculation[@R1]:

Regarding O~3~ exposure, these RR estimates can be converted into an estimated β using the following equation where ΔO~3~ is a specified change in pollutant (ie, for a 10 μg/m^3^ increase)[@R24]:

Then, the difference between current ozone (8 h mean) and a counterfactual level is used to calculate RR as follows[@R24]:

These RR estimates are subsequently applied to determine the AF as stated before. Ultimately, the expected number of deaths is calculated by[@R1]:

where M, mortality rate; P, exposed population size.

The previous steps come with a range of assumptions and uncertainties. To reflect these uncertainties results are presented with a point estimate as well as an upper and lower bound given by the 95% CI of the CRF.ADs and TADs estimates were rounded off to the nearest whole number.

Results {#s3}
=======

[Table 4](#BMJOPEN2014005999TB4){ref-type="table"} shows the impact (in terms of mortality) of the estimated current ambient levels of pollutants relative to the assumed background concentrations and the benefit of reducing pollutant concentrations to the levels set as targets by the WHO AQG or the Directive 2008/50/EC. Our estimates point out that compliance with the WHO AQG target values might result in higher savings, in terms of mortality avoided, than with the Directive 2008/50/EC standards. Morbidity adverse health effects are not included in the assessment.

###### 

Annual number of deaths (deaths per year) from outdoor air pollution for 1999--2008

  All-cause mortality and short-term exposure to PM~10~: all ages[@R1]                                          
  ---------------------------------------------------------------------- ------- ------ -------- ------ ------- -----
   Indicator                                                             AFs     TADs   AFs      TADs   AFs     ADs
   Lower estimate                                                        0.92    24     −0.276   −7     1.513   39
   Central estimate                                                      1.225   31     −0.368   −9     2.012   52
   Higher estimate                                                       1.529   39     −0.46    −12    2.509   64

  All-cause mortality and short-term exposure to PM~10~: age \<5 years\*                                         
  ------------------------------------------------------------------------ ------- ------ -------- ------ ------ -----
   Indicator                                                               AFs     TADs   AFs      TADs   AFs    ADs
   Lower estimate                                                          0.523   0      −0.156   0      0.86   0
   Central estimate                                                        2.526   0      −0.765   0      4.13   0
   Higher estimate                                                         4.518   1      −1.386   0      7.34   1

  All-cause mortality and long-term exposure to PM~2.5~: age \>30 years[@R8]                                           
  ---------------------------------------------------------------------------- -------- ------ ------- ------ -------- -----
   Indicator                                                                   AFs      TADs   AFs     TADs   AFs      ADs
   Lower estimate                                                              6.027    153    0.333   8      8.572    217
   Central estimate                                                            9.094    231    0.510   13     12.842   326
   Higher estimate                                                             11.872   301    0.675   17     16.656   422

  Cardiopulmonary mortality and long-term exposure to PM~2.5~: age \>30 years[@R1]                                           
  ---------------------------------------------------------------------------------- -------- ------ ------- ------ -------- -----
   Indicator                                                                         AFs      TADs   AFs     TADs   AFs      ADs
   Lower estimate                                                                    4.891    36     0.181   1      10.148   74
   Central estimate                                                                  12.929   94     0.498   4      25.577   186
   Higher estimate                                                                   20.288   148    0.814   6      38.356   280

  Lung cancer mortality and long-term exposure to PM~2.5~: age \>30 years[@R1]                                            
  ------------------------------------------------------------------------------ --------- ------ ------- ------ -------- -----
   Indicator                                                                     AFs       TADs   AFs     TADs   AFs      ADs
   Lower estimate                                                                7\. 357   10     0.275   0      15.044   21
   Central estimate                                                              18.713    27     0.744   1      35.729   51
   Higher estimate                                                               28.678    41     1.211   2      51.378   73

  All-cause mortality and short-term exposure to O~3~: all ages                                         
  --------------------------------------------------------------- ------- ------ ------- ------ ------- -----
   Indicator                                                      AFs     TADs   AFs     TADs   AFs     ADs
  *Source of risk estimates: Anderson et al* [@R20]                                                     
   Lower estimate                                                 0.207   5      0.107   3      0.356   9
   Central estimate                                               0.823   21     0.426   11     1.416   36
   Higher estimate                                                1.435   37     0.744   19     2.463   63
  *Source of risk estimates: HRAPIE Project*[@R8]                                                       
   Lower estimate                                                 0.577   15     0.299   8      0.994   25
   Central estimate                                               1.191   31     0.617   16     2.046   52
   Higher estimate                                                1.760   45     0.913   23     3.016   77

  Respiratory mortality and short-term exposure to O~3~: all ages                                            
  ----------------------------------------------------------------- -------- ------ -------- ------ -------- -----
   Indicator                                                        AFs      TADs   AFs      TADs   AFs      ADs
  *Source of risk estimates: Anderson et al* [@R20]                                                          
   Lower estimate                                                   −2.096   −6     −1.077   −3     −3.642   −10
   Central estimate                                                 −0.415   −1     −0.214   −1     −0.717   −2
   Higher estimate                                                  1.638    4      0.85     2      2.809    7
  *Source of risk estimates: HRAPIE Project*[@R8]                                                            
   Lower estimate                                                   −0.456   −1     −0.236   −1     −0.789   −2
   Central estimate                                                 1.191    3      0.617    2      2.046    5
   Higher estimate                                                  2.845    8      1.480    4      4.857    13

  Cardiovascular mortality and short-term exposure to O~3~: all ages                                         
  -------------------------------------------------------------------- ------- ------ ------- ------ ------- -----
   Indicator                                                           AFs     TADs   AFs     TADs   AFs     ADs
  *Source of risk estimates: Anderson et al* [@R20]                                                          
   Lower estimate                                                      1.232   11     0.638   6      2.115   18
   Central estimate                                                    1.638   14     0.85    7      2.809   25
   Higher estimate                                                     2.042   18     1.06    9      3.497   31
  *Source of risk estimates: HRAPIE Project*[@R8]                                                            
   Lower estimate                                                      0.536   5      0.277   2      0.923   8
   Central estimate                                                    2.002   17     1.039   9      3.429   30
   Higher estimate                                                     3.441   30     1.793   16     5.862   51

Counterfactual concentrations:

\*Target concentration from WHO.[@R23]

†Target concentration from Directive 2008/50/EC.[@R19]

‡Background level from Ostro.[@R1]

§Background level from WHO.[@R23]

ADs, attributable deaths; AFs, attributable fractions; HRAPIE, Health risks of air pollution in Europe; PM, particulate matter; TADs, targeted avoidable deaths.

This table presents the annual number of ADs and TADs (deaths per year) for the period 1999--2008 along with their corresponding AFs (multiplied by 100 to express as percentage).

As for the TADs, which estimate the number of deaths that could have been avoided in case of having reduced the air pollutant concentrations to the levels set as a target, the AFs estimate the proportional reduction of the mortality cause that could have been prevented in case of having decreased to the target scenario the exposure to the air pollutant. Regarding the ADs, which estimate the number of deaths due to current air pollution concentrations relative to the assumed background levels, the AFs estimate the proportion of the mortality cause that could have been attributed to those pollutants.

ADs and TADs estimates were rounded off to the nearest whole number. For this reason, zero values for ADs and TADs are calculated for all-cause mortality related to PM~10~ for \<5 years and for lung cancer mortality related to PM~2.5~ in \>30 years under the Directive 2008/50/EC exposure scenario (25 µg/m^3^**)**. Negative estimates, which should be read as zero, were obtained when current pollutant concentrations were below the counterfactual value assumed (Directive 2008/50/EC exposure scenario for all-cause mortality related to exposure to PM~10~) or assumed risk coefficients were below 1 (for respiratory mortality related to exposure to O~3~: the lower and central risk estimates revised for publication bias from Anderson *et al* and the lower risk estimate from HRAPIE project). Likewise, since annual average for 1999--2008 of respiratory mortality for children \<5 years old was rounded off to zero, ADs and TADs estimates for respiratory mortality related to PM~10~ exposure for this age group resulted null and are not presented. It bears noting that AFs of respiratory mortality for children \<5 years are the same as for all-cause mortality.

When applying the more stringent WHO target values scenarios, higher TADs and AFs estimates than under Directive 2008/50/EC exposure conditions were obtained. Overall, estimates for the mortality related to PM~2.5~ exposure were higher than for PM~10~ and O~3~. Specifically, for cardiopulmonary and lung cancer mortality associated to PM~2.5~ exposure, notable AFs were obtained and the CIs show quite a broader range than those for mortality related to PM~10~ and O~3~.

Concerning mortality associated to O~3~ exposure, central and higher estimates were slightly larger when assuming the risk coefficients derived from the HRAPIE project than those from Anderson *et al.* For respiratory mortality, negative estimates were obtained as described previously. CIs range is narrower than for mortality estimates associated to PM~2.5~. The overall picture from the two sets of coefficients assumed might be considered similar.

[Table 5](#BMJOPEN2014005999TB5){ref-type="table"} provides the estimates for the different input parameters evaluated as a sensitivity analysis.

###### 

Effects of alternative assumptions on annual number of deaths estimates (deaths per year)

  All-cause mortality and long-term exposure to PM~2.5~: age \>30 years[@R8]                                                                                            
  ---------------------------------------------------------------------------- ----------------------------------------- ------ -------- ------ -------- ----- -------- -----
   Indicator                                                                   AFs                                       TADs   AFs      TADs   AFs      ADs   AFs      ADs
   Lower estimate                                                              6.027                                     153    0.333    8      8.572    217   6.944    176
   Central estimate                                                            9.094                                     231    0.510    13     12.842   326   10.451   265
   Higher estimate                                                             11.872                                    301    0.675    17     16.656   422   13.611   345
                                                                               PM~2~.~5~/PM~10~ ratio: 0.65[@R1] [@R8]                                                  
   Lower estimate                                                              4.977                                     126    −0.781   −20    7.551    191   5.904    150
   Central estimate                                                            7.532                                     191    −1.200   −30    11.344   288   8.912    226
   Higher estimate                                                             9.859                                     250    −1.594   −40    14.752   374   11.638   295

  Cardiopulmonary mortality and long-term exposure to PM~2.5~: age \>30 years[@R1]                                                                                          
  ---------------------------------------------------------------------------------- --------------------------------------- ------ -------- ------ -------- ----- -------- -----
   Indicator                                                                         AFs                                     TADs   AFs      TADs   AFs      ADs   AFs      ADs
   Lower estimate                                                                    4.891                                   36     0.181    1      10.148   74    6.26     46
   Central estimate                                                                  12.929                                  94     0.498    4      25.577   186   16.344   119
   Higher estimate                                                                   20.288                                  148    0.814    6      38.356   280   25.343   185
                                                                                     PM~2.5~/PM~10~ ratio: 0.65[@R1] [@R8]                                                  
   Lower estimate                                                                    4.294                                   31     −0.447   −3     9.583    70    5.670    41
   Central estimate                                                                  11.410                                  83     −1.238   −9     24.278   177   14.884   109
   Higher estimate                                                                   17.997                                  131    −2.036   −15    36.585   267   23.198   169

                      Linear relationship[@R1]                                                               
  ------------------- --------------------------------------- ------ -------- ------ -------- ----- -------- -----
   Indicator          AFs                                     TADs   AFs      TADs   AFs      ADs   AFs      ADs
   Lower estimate     4.976                                   36     0.273    2      7.094    52    5.738    42
   Central estimate   13.198                                  96     0.756    6      18.458   135   15.114   110
   Higher estimate    20.709                                  151    1.237    9      28.432   207   23.558   172
                      PM~2.5~/PM~10~ ratio: 0.65[@R1] [@R8]                                                  
   Lower estimate     4.105                                   30     −0.641   −5     6.242    46    4.874    36
   Central estimate   10.974                                  80     −1.786   −13    16.369   119   12.940   94
   Higher estimate    17.351                                  126    −2.945   −21    25.402   185   20.322   148
                                                                                                             

  Lung cancer mortality and long-term exposure to PM~2.5~: age \>30 years[@R1]                                                                                          
  ------------------------------------------------------------------------------ --------------------------------------- ------ -------- ------ -------- ----- -------- -----
   Indicator                                                                     AFs                                     TADs   AFs      TADs   AFs      ADs   AFs      ADs
   Lower estimate                                                                7.357                                   10     0.275    0      15.044   21    9.38     13
   Central estimate                                                              18.713                                  27     0.744    1      35.729   51    23.437   33
   Higher estimate                                                               28.678                                  41     1.211    2      51.378   73    35.313   50
                                                                                 PM~2.5~/PM~10~ ratio: 0.65[@R1] [@R8]                                                  
   Lower estimate                                                                6.468                                   9      −0.682   −1     14.229   20    8.510    12
   Central estimate                                                              16.582                                  24     −1.859   −3     34.044   48    21.429   30
   Higher estimate                                                               25.602                                  36     −3.050   −4     49.281   70    32.523   46

                      Linear relationship[@R1]                                                               
  ------------------- --------------------------------------- ------ -------- ------ -------- ----- -------- -----
   Indicator          AFs                                     TADs   AFs      TADs   AFs      ADs   AFs      ADs
   Lower estimate     6.618                                   9      0.367    1      9.4      13    7.621    11
   Central estimate   18.194                                  26     1.071    2      25.137   36    20.745   29
   Higher estimate    28.335                                  40     1.771    3      38.141   54    32.004   45
                      PM~2.5~/PM~10~ ratio: 0.65[@R1] [@R8]                                                  
   Lower estimate     5.468                                   8      −0.860   −1     8.284    12    6.484    9
   Central estimate   15.204                                  22     −2.544   −4     22.401   32    17.848   25
   Higher estimate    23.938                                  34     −4.256   −6     34.345   49    27.832   40

  All-cause mortality and short-term exposure to O~3~: all ages                         
  --------------------------------------------------------------- ------- ----- ------- -----
   Indicator                                                      AFs     Ads   AFs     ADs
  *Source of risk estimates: Anderson et al* [@R20]                                     
   Lower estimate                                                 0.356   9     0.456   12
   Central estimate                                               1.416   36    1.809   46
   Higher estimate                                                2.463   63    3.142   81
  *Source of risk estimates: HRAPIE Project* [@R8]                                      
   Lower estimate                                                 0.994   25    1.270   33
   Central estimate                                               2.046   52    2.611   67
   Higher estimate                                                3.016   77    3.845   99

  Respiratory mortality and short-term exposure to O~3~: all ages                           
  ----------------------------------------------------------------- -------- ----- -------- -----
   Indicator                                                        AFs      Ads   AFs      ADs
  *Source of risk estimates: Anderson et al* [@R20]                                         
   Lower estimate                                                   −3.642   −10   −4.687   −12
   Central estimate                                                 −0.717   −2    −0.918   −2
   Higher estimate                                                  2.809    7     3.582    10
  *Source of risk estimates: HRAPIE Project *[@R8]                                          
   Lower estimate                                                   −0.789   −2    −1.011   −3
   Central estimate                                                 2.046    5     2.611    7
   Higher estimate                                                  4.857    13    6.175    16

  Cardiovascular mortality and short-term exposure to O~3~: all ages                         
  -------------------------------------------------------------------- ------- ----- ------- -----
   Indicator                                                           AFs     ADs   AFs     ADs
  *Source of risk estimates: Anderson et al* [@R20]                                          
   Lower estimate                                                      2.115   18    2.7     24
   Central estimate                                                    2.809   25    3.582   31
   Higher estimate                                                     3.497   31    4.455   39
  *Source of risk estimates: HRAPIE Project* [@R8]                                           
   Lower estimate                                                      0.923   8     1.180   10
   Central estimate                                                    3.429   30    4.368   38
   Higher estimate                                                     5.862   51    7.443   65

Counterfactual concentrations:

*Counterfactual concentration*: \*Target concentration (background level for mortality and short-term exposure to O~3~) from WHO.[@R23]

†Target concentration from Directive 2008/50/EC.[@R19]

‡Background level from Ostro.[@R1]

§Background level from Pope III.[@R22]

¶Background level from Amann *et al.*[@R3]

ADs, attributable deaths; AFs, attributable fractions; HRAPIE, Health risks of air pollution in Europe; PM, particulate matter; TADs, targeted avoidable deaths.

Overall, for long-term effects of PM~2.5~ exposure, the results remained within the range calculated on the basis of the recommended parameters. For the alternative PM~2.5~/PM~10~ ratio of 0.65, negative TADs estimates were obtained as the counterfactual level of 25 µg/m^3^ (Directive 2008/50/EC) was higher than the estimated PM~2.5~ concentration of 23.01 µg/m^3^ for the alternative ratio. Broadly, estimates under the recommended ratio of 0.73 were higher than under the alternative assumption of 0.65.

Regarding the shape of the model, slightly higher estimates were obtained under the recommended log-linear model. As for the alternative background level of 7.5 µg/m^3^, lower estimates than for the recommended background concentration of 3 µg/m^3^ were calculated.

Concerning mortality associated with short-term exposure to O~3~, slightly higher ADs estimates than for the suggested background level of 70 µg/m^3^ were obtained under the alternative background level of 50 µg/m^3^ for both sets of risk coefficients. Negative estimates were also obtained as described before.

Discussion {#s4}
==========

This HIA study pointed to a detrimental effect on mortality from PM~10~, PM~2.5~ and O~3~ exposure. Our estimates indicated a higher number of avoidable deaths from reducing pollutant concentrations to the WHO AQG levels than from a reduction to the European Union (EU) standards. The impact would have been greater if attainment of the legal standards at the moment had not been achieved.

When negative or null estimates were obtained, no deaths would have been possible to attribute or prevent relative to the exposure scenarios considered.

Comparison with other studies {#s4a}
-----------------------------

HIA is an underutilised tool in Spain.[@R25] To the best of our knowledge, there are no Spanish studies that have followed this EBD series guideline on outdoor air pollution.[@R1] Estimates of the burden of disease associated to air pollution were calculated in various Spanish cities within the framework of different European[@R26] and Spanish[@R29] projects. A study estimated the health and economic benefits resulting from two scenarios of improved air quality (EU standards and WHO targets) in Barcelona.[@R46] Two recent studies estimated the number of avoidable deaths associated with reducing PM~2.5~ in Spain.[@R47] [@R48] The heterogeneity of exposure data and methods used in the studies conducted in Spain do not let compare properly their results with our estimates. However, our estimates follow the trend showed by the literature.

Strengths and weaknesses of this study {#s4b}
--------------------------------------

This type of analysis has a range of inherent uncertainties and methodological limitations that must be considered when interpreting our estimates. Limitations can affect every step of the method.[@R1]

CIs only cover statistical uncertainty related to the risk estimates.Our estimates are sensitive to the alternative assumptions for PM~2.5~/PM~10~ ratio, background concentration and shape of CRF. Although the risk parameters are never completely transferable from one population to another, the methods and CRFs summarised by the WHO applied in our study provide the most appropriate, albeit imperfect, effect estimates. The methodology described in the current EBD series can be adapted both to local and national levels. The updated guidance and risk coefficients arising from the review process coordinated by the WHO would provide more accurate estimates of the impact on health that will be used to revise our results.

Caution must be taken as short-term estimates should not be added to long-term estimates or estimates for children since adding them would involve double count.[@R1] As mentioned previously, the estimates for all-cause mortality associated with short-term exposure to PM~10~ for \<5 years might result in an overestimate.[@R1] Probably no deaths would have been possible to attribute or prevent in children \<5 years old related to short-term exposure to PM~10~. It should be emphasised that the HRAPIE report indicates that generalisation of the recommended approaches to other regions of the globe or individual countries, or to particular mixtures at the local level, may be not appropriate. Specifically, risk estimates for certain health outcomes exhibit more uncertainty. It bears noting that the background national data on all-cause mortality have greater precision than the cause-specific data. The latter may be affected by misclassification of causes of death in mortality registration.[@R8]

Our estimates of mortality associated to long-term exposure to PM~2.5~ show quite a large range. Reality is likely to lie in between. Probably differences in mortality rates and the proportion of population in age groups affect our results. Likely a data set including a longer period of analysis would have provided a better scope of the real impact of PM~2.5~.

Regarding the ambient exposure of the population, our results are affected by the ecological fallacy because of using ecological data on exposure to pollutants. We have also underestimated the effect of outdoor air pollution as morbidity adverse health effects, which impose a considerable health burden, are not included in the assessment. Similarly, assuming independence of the effects of pollutants could overestimate our results.

Our data (described in [table 1](#BMJOPEN2014005999TB1){ref-type="table"}) are based on a network of fixed-site monitors whose location, number and range of pollutants measured have changed over time, decreasing the quality and robustness of our exposure estimates. Equally, the effect on averages of outliers, street canyon effect and hot spot sites can overestimate our results.

Likewise, PM~10~ concentration data corrected for sub-Saharan dust intrusions were not available. In the absence of local data on fine particle matter, PM~2.5~ levels were estimated from the recommended PM~2.5~/PM~10~ ratio.[@R1] There is a lack of a municipal emission source inventory and of local data for background levels of the pollutants considered in our study. In addition, the impact of other co-pollutants and seasonal effects (for instance the strong seasonal cycle for O~3~, high in summer and low in winter) can influence our estimates. Therefore, although presenting our results with a CI can provide a range for our estimates and set bounds to statistical error, we cannot diminish the uncertainty embodied in our results by the quality of the exposure data and our assumptions to estimate population exposure.

Meaning of the study and directions for future research {#s4c}
-------------------------------------------------------

The WHO EBD series framework seems to prove useful to apply at local level. Our estimates, although constrained by major uncertainties, should be a quantitative input to local authorities become aware of the magnitude of the problem, help realise the substantial potential health benefits from compliance with WHO AQG target values and prioritise actions on strengthening control of outdoor air pollution.

Local governments, through policies aimed mainly to reduce emissions from urban transport that provide alternatives to private motor vehicle traffic, could achieve considerable health gains. It must be stressed that these strategies, through synergies between policies, may yield other important co-benefits for health in traffic injury prevention, noise reduction, creation of spaces for exercise and recreation, etc.[@R1] Actions should be taken to provide the population with this kind of information, since their awareness and active participation are basic to reduce air pollution.

As implications for future research, the recommendations and risk coefficients resulting from the current evidence review process led by the WHO will be used to revise and update our estimates. Likewise, the analysis with local measurements of PM~2.5~ to reduce uncertainty of estimates related to this pollutant should also be conducted. Collective efforts for developing the availability of morbidity data are needed in order to improve the evaluation of the burden of disease. Future research on improving the monitoring and description of the urban atmosphere and the background levels of pollutants in our local and regional setting should be developed.

Conclusions {#s4d}
-----------

Our study suggests a not negligible impact on mortality of outdoor air pollution by PM~10~, PM~2.5~ and O~3~. The implementation of the EBD series guideline on outdoor air pollution[@R1] compiled by the WHO provides critical information to distinguish an improvement range in air pollution control.

Our results support a reflection on the opportunities to develop feasible actions in order to adopt the more stringent WHO targets, yielding more benefits than simply attaining the current Directive 2008/50/EC, and to enhance the monitoring of ambient air quality at local level.

In any case, we cannot forget that small reductions in the levels of risk factors may yield a great benefit for the health of the entire population.
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